Phathom Pharmaceuticals, Inc. — Director's Dealing 2022

Sep 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2022-09-01

Reporting Person: Henderson Molly (CFO and CBO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-01	Common Stock	A	7500	$0.00	Acquired	45500	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	338.86	Indirect

Footnotes

F1: Represents restricted stock units ("RSUs") granted on September 1, 2022. Fifty percent (50%) of the total number of RSUs granted vest on each of March 1, 2023 and June 1, 2023, subject to the Reporting Person's continued service on each applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

F2: Includes 338.86 shares acquired under the Phathom Pharmaceuticals, Inc. 401(k) plan.